0001062993-23-017146.txt : 20230828
0001062993-23-017146.hdr.sgml : 20230828
20230828132948
ACCESSION NUMBER: 0001062993-23-017146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230825
FILED AS OF DATE: 20230828
DATE AS OF CHANGE: 20230828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHWARTZ NORMAN D
CENTRAL INDEX KEY: 0000940805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 231213753
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC.
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
FORMER COMPANY:
FORMER CONFORMED NAME: BIO RAD LABORATORIES INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-25
0000012208
BIO-RAD LABORATORIES, INC.
BIO BIOB
0000940805
SCHWARTZ NORMAN D
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
1
1
1
0
Chairman, President, and CEO
0
Bio-Rad A Common Stock
2023-08-25
4
M
0
2081
0
A
429925
D
Bio-Rad A Common Stock
2023-08-25
4
F
0
1032
381.78
D
428893
D
Bio-Rad A Common Stock
2023-08-25
4
M
0
1266
0
A
430159
D
Bio-Rad A Common Stock
2023-08-25
4
F
0
628
381.78
D
429531
D
Bio-Rad A Common Stock
2023-08-25
4
M
0
1805
0
A
431336
D
Bio-Rad A Common Stock
2023-08-25
4
F
0
895
381.78
D
430441
D
Bio-Rad A Common Stock
2023-08-25
4
M
0
2320
0
A
432761
D
Bio-Rad A Common Stock
2023-08-25
4
F
0
1151
381.78
D
431610
D
Bio-Rad A Common Stock
2023-08-25
4
M
0
2600
0
A
434210
D
Bio-Rad A Common Stock
2023-08-25
4
F
0
1290
381.78
D
432920
D
Bio-Rad B Common Stock
2023-08-25
4
M
0
39000
117.50
A
370689
D
Bio-Rad B Common Stock
2023-08-25
4
F
0
25389
381.78
D
345300
D
Bio-Rad B Common Stock
12900
I
By Spouse
Bio-Rad B Common Stock
4060054
I
By Blue Raven Partners, L.P.
Restricted Stock Units
0
2023-08-25
4
M
0
2081
0
D
Bio-Rad A Common Stock
2081
6245
D
Restricted Stock Units
0
2023-08-25
4
M
0
1266
0
D
Bio-Rad A Common Stock
1266
2532
D
Restricted Stock Units
0
2023-08-25
4
M
0
1805
0
D
Bio-Rad A Common Stock
1805
1805
D
Restricted Stock Units
0
2023-08-25
4
M
0
2320
0
D
Bio-Rad A Common Stock
2320
2320
D
Restricted Stock Units
0
2023-08-25
4
M
0
2600
0
D
Bio-Rad A Common Stock
2600
0
D
Non-Qualified Stock Option (right to buy)
117.50
2023-08-25
4
M
0
39000
0
D
2023-09-11
Bio-Rad B Common Stock
39000
0
D
Shares of Class A common stock acquired on the vesting of restricted stock units.
The reporting person disclaims beneficial ownership of these shares.
The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023.
The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted.
/s/ Norman Schwartz
2023-08-28